Global Oncology Market Revenues to Cross USD 241 Bn by 2023, Forecasts GBI Research in Its Topical Report Recently Uploaded at MarketPublishers.com
26 Jul 2017 • by Natalie Aster
LONDON – As of 2012, around 32.6 million people were living with any type of cancer within 5 years of diagnosis. These are usually incurable once they progress to the stage where they are unresectable. Today, chemotherapy is the most popular treatment option for cancers of all types, at different diseases stages.
Common etiological factors which raises the risk of developing cancer include chronic inflammation, age, obesity, gender, heritage cancer syndromes and tobacco usage. The risk of cancer increases considerably in patients at the 65+ age.
A shift towards the development of targetd therapies (like cell and mAbs therapies) has been recently registered in the oncology drugs pipeline. Targeted therapies are characterised by less toxicity.
In 2016, the global oncology market generated revenues of USD 118.6 billion. Through 2023, the market revenues are likely to increase at a high CAGR of 10.66% to cross USD 241 billion by the end of the projected period.
At present, the oncology drugs pipeline is large and diverse, it includes 7,773 products.
The topical report “Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors” worked out by GBI Research provides a clear understanding of the current oncology market landscape and presents a detailed analysis of the oncology drugs pipeline. It covers the disease pathogenesis, prognosis, diagnosis and existing treatment option. Besides, this publication includes data on the major forces influencing the market growth, highlights the situation across the key segments, reviews the most recent developments and product launches, canvasses the prevailing and emerging trends. Moreover, this report outlines the emerging opportunities and gives forecasts for the oncology market development up to 2023.
Find many other in-demand topical studies by the publisher in the GBI Research catalogue at MarketPublishers.com.